Genipin

DB19124InvestigationalSmall molecule

Genipin is under investigation in clinical trial NCT05755750 (Intratendinous Genipin Injection in Horses With Tendon Injuries).

Mechanism: Pharmacologically active on Dicarboxylate carrier SLC25A8
Curator reviewed
Formula / weight: C₁₁H₁₄O₅ · 226.228 g/mol (avg)
Also known as: (+)-genipin · Cyclopenta(c)pyran-4-carboxylic acid, 1,4a,5,7a-tetrahydro-1-hydroxy-7-(hydroxymethyl)-, methyl ester, (1r-(1.alpha.,4a.alpha.,7a.alpha.))- · Cyclopenta(c)pyran-4-carboxylic acid, 1,4a,5,7a-tetrahydro-1-hydroxy-7-(hydroxymethyl)-, methyl ester, (1r,4as,7as)- · Cyclopenta(c)pyran-4-carboxylic acid, 1,4a.alpha.,5,7a.alpha.-tetrahydro-1-hydroxy-7-(hydroxymethyl)-, methyl ester

Resolves to

Compound

Structure

InChIKeyAZKVWQKMDGGDSV-BCMRRPTOSA-NSMILES[H][C@]12CC=C(CO)[C@@]1([H])[C@H](O)OC=C2C(=O)OC

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Genipin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.